J. Hall

Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA.

AdipoGenix, Inc. develops molecular pharmaceutical products. It offers small molecule pharmaceuticals to treat obesity and its co-morbidities. The firm’s technology includes AdipoBASE, AdipoSCREEN, AdipoPATH and AdipoTARGET. The company was founded by Gerri Waloga, Barbara E. Corkey, Stephen R. Farmer, James A. Hamilton, James L. Kirkland, H. Jeff Leighton and Paul F. Pilch in 1997 and is headquartered in Boston, MA.

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

AIG Brunswick Millennium Fund seeks investment opportunities in companies located in Russia, the Baltic States and other nations of the former Soviet Union. The fund targets companies operating in large infrastructure projects include power, transportation, natural resource development and related industries. It provides financing for buyout capital requirements with a minimum investment size of $7 million.

The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom.

Molecular Securities, Inc. provides investment banking services. The private company is based in New York, NY.

PineBridge Capital Partners LLC is a private equity firm located in New York City. The firm is a subsidiary of PineBridge Private Equity Group Partners and their ultimate parent is Hong Kong-based Pacific Century Group.

Agrisoma Biosciences, Inc. provides crop technology for biofuel and renewable energy solutions. Its crop improvement technologies include proprietary breeding, proprietary tissue culture and haploidy, molecular markers and genetic mapping and advanced crop improvement technologies. The company was founded by Steven Fabijanski and Tom Mamic in 2001 and is headquartered in Gatineau, Canada.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Praxim SA manufactures and sells orthopedic surgical instruments. It specializes in minimal invasive products for knee arthroscopy. The company was founded by Stéphane Lavallée in 1995 and is headquartered in La Tronche, France.

Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada.

BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada.

TraumaTec, Inc. manufactures medical devices. It develops patented, non-invasive, and disposable medical device that specifically targets cooling the brain to mitigate brain injury. The company was founded on March 25, 2003 and is headquartered in Houston, TX.

Bloom Burton & Co. is an independent, Canadian broker/dealer headquartered in Toronto, Ontario. It was founded by Brian Bloom and Jolyon Burton in 2008. The firm offers bespoke execution services for healthcare institutional investors. They are active in all areas of the healthcare industry, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition and wellness.

The Ottawa Hospital Research Institute is based in Ottawa, CA. The Canadian company provides world-class care with compassionate people.

Part of Fate Therapeutics, Inc., Verio Therapeutics, Inc. is a Canadian pharmaceutical company that manufactures products for activating endogenous stem cells. The company is based in Ottawa, Canada. Verio Therapeutics was acquired by Fate Therapeutics, Inc. on April 08, 2010. The company was founded by Frank Gleeson, Michael Rudnicki.

Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX.

Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada.

The Ontario Institute For Regenerative Medicine provides stem cell and regenerative medicine research services. The company was founded by on November 25, 2014 and is headquartered in Toronto, Canada.

ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada.

Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.

Grey Wolf Animal Health, Inc. provides animal health products. The firm offers in-house development and the in-license of mature products. The company was founded by Ian Sandler in March 2015 and is headquartered in Toronto, Canada.

Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018.